We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

148 hedge funds and large institutions have $318M invested in Spectrum Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 8

232% more call options, than puts

Call options by funds: $385K | Put options by funds: $116K

17% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 42

16% more funds holding

Funds holding: 128148 (+20)

15% less capital invested

Capital invested by funds: $375M → $318M (-$56.8M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
148
Holders Change
+20
Holders Change %
+15.63%
% of All Funds
4.13%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
29
Increased
49
Reduced
42
Closed
8
Calls
$385K
Puts
$116K
Net Calls
+$269K
Net Calls Change
-$453K
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$35M -$904K -130,152 -2%
State Street
2
State Street
Massachusetts
$29.2M -$919K -132,396 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$27.7M +$2.21M +318,182 +7%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$25.4M
BC
5
Broadfin Capital
New York
$15.1M -$925K -133,252 -5%
Renaissance Technologies
6
Renaissance Technologies
New York
$10.6M -$86.1K -12,400 -0.7%
BIT
7
BlackRock Institutional Trust
California
$10.6M -$1.25M -180,222 -9%
Goldman Sachs
8
Goldman Sachs
New York
$8.09M -$1.17M -168,763 -11%
ACA
9
Avoro Capital Advisors
New York
$7.87M +$9.13M +1,315,600 New
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$7.39M -$19.7K -2,844 -0.2%
ACM
11
Ashford Capital Management
Delaware
$7.32M -$174K -25,127 -2%
KAM
12
Krensavage Asset Management
New York
$6.45M +$1.63M +234,800 +28%
Macquarie Group
13
Macquarie Group
Australia
$6.19M +$1.47M +212,316 +26%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$6.09M -$13K -1,876 -0.2%
Deutsche Bank
15
Deutsche Bank
Germany
$5.95M +$2.7M +388,959 +64%
Charles Schwab
16
Charles Schwab
California
$5.56M +$291K +41,885 +5%
Barclays
17
Barclays
United Kingdom
$5.35M +$491K +70,718 +7%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$4.76M +$692K +99,711 +14%
PAM
19
Panagora Asset Management
Massachusetts
$4.46M +$522K +75,210 +11%
Northern Trust
20
Northern Trust
Illinois
$4.25M -$2.94K -423 -0.1%
TA
21
Teachers Advisors
New York
$4.21M +$347K +50,050 +8%
Millennium Management
22
Millennium Management
New York
$4.09M -$10.9M -1,565,669 -70%
NI
23
Numeric Investors
Massachusetts
$4.03M +$4.52M +651,300 +2,908%
Wells Fargo
24
Wells Fargo
California
$3.41M -$39.3K -5,656 -1%
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$3.26M +$3.79M +545,893 New

SPPI Hedge Fund Activity: Q3 2015 in Review

148 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2015, worth a combined $318M — down 15% from $375M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SPPI positions and 8 closed out — a net gain of 21 holders — while 49 added to existing stakes and 42 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $9.13M. The largest seller was Armistice Capital, exiting entirely with an estimated $30.3M sold.

  • 148 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2015, up from 128 in Q2 2015.
  • Funds reported $318M of Spectrum Pharmaceuticals Inc stock for Q3 2015, down 15% quarter-over-quarter.
  • 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2015 and 8 closed out, a net change of +21 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2015 was Avoro Capital Advisors, an estimated $9.13M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2015 was Armistice Capital, an estimated $30.3M sold.

Based on aggregated 13F filings for Q3 2015.